Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates.
about
Antimicrobial drug prescribing for pneumonia in ambulatory careBiological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.Emergence of a Streptococcus pneumoniae clinical isolate highly resistant to telithromycin and fluoroquinolones.Nonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae.Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics.High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniaeFluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniaeRole of beta-lactam agents in the treatment of community-acquired pneumonia.Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation.Real-time PCR detection of gyrA and parC mutations in Streptococcus pneumoniae.In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.Resistance to Macrolide Antibiotics in Public Health Pathogens.Properties of novel international drug-resistant pneumococcal clones identified in day-care centers of Lisbon, Portugal.Rapid screening of topoisomerase gene mutations by a novel melting curve analysis method for early warning of fluoroquinolone-resistant Streptococcus pneumoniae emergenceIn vitro activity of garenoxacin against Streptococcus pneumoniae mutants with characterized resistance mechanismsEvaluation of melting curve analysis for screening the most prevalent mutations in topoisomerase genes from Streptococcus pneumoniae.Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.Fatal levofloxacin failure in treatment of a bacteremic patient infected with Streptococcus pneumoniae with a preexisting parC mutation.What Is the Clinical Impact of Macrolide Resistance?Molecular Basis of Macrolide Resistance in Strains Isolated from Poultry in South Korea
P2860
Q24620235-D75F58A2-6867-4F4C-9346-C8CA1FB43ECFQ30251593-37138A50-DE0F-4B4E-8128-684394E82380Q33883600-F324FC6B-D1F3-4E90-ADE3-63A2E1772A03Q34143934-15020173-E255-40F0-B8A7-F79A62FF7337Q34352053-32547B36-591E-45BF-8C99-40F00C06F380Q35635640-744371A0-2CA1-4EDB-ADCC-2DABDA32EC2EQ35647682-724CCD5E-84E5-4BF5-B5C0-E97191446853Q35880792-80DD4B55-0892-4812-8B41-B8924A84711CQ36009308-0909A1A4-B89E-47E1-8EDA-A80D40ABB2B1Q36032899-3335C3DB-8D72-435E-82C6-80E53C8949E2Q36071245-2663BBCA-1CC1-4758-BFA0-877A1088F010Q36337074-4BD1DA9B-9537-4A68-8FFC-1799E4AAD6C3Q36339849-4B2359C1-063A-43BB-850C-93218C526EF6Q36425045-0B2826F7-6714-4157-861C-12C6598BEBFFQ36949499-66BF6138-11BE-4BFE-A639-10CA22BD4826Q37488975-04A97D6B-05C1-46CC-907D-B80EE96E0ED2Q37998398-F94F5B65-CFF2-4156-9F4D-E9B17A7BACB8Q38928353-E7C318E4-CD41-46AD-9670-62A6389AA06EQ40391197-946F7CCD-A1BF-49A3-85CD-B238D48551B4Q41071092-1086F374-6C97-469A-9098-578685391F31Q41840910-74159F9D-67B5-48E5-AE9F-0DE0B0C4F8BAQ43002673-65385CC1-63EE-41DE-AA85-9DA8787D4220Q43063844-1FBDAC21-D55F-4AFF-A9E7-ABA9AB67E0A4Q43069250-720FF373-B801-4301-9077-A97F326DE33BQ43112313-813C960B-08F2-4855-8E8E-EFD3049B03E9Q48029140-036F3D5C-5D82-4C1F-9A1E-FBA5B264B90EQ57211279-2CC60F81-2F3C-489D-9F92-76897649DD06
P2860
Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Fluoroquinolone and macrolide ...... multidrug-resistant isolates.
@ast
Fluoroquinolone and macrolide ...... multidrug-resistant isolates.
@en
Fluoroquinolone and macrolide ...... multidrug-resistant isolates.
@nl
type
label
Fluoroquinolone and macrolide ...... multidrug-resistant isolates.
@ast
Fluoroquinolone and macrolide ...... multidrug-resistant isolates.
@en
Fluoroquinolone and macrolide ...... multidrug-resistant isolates.
@nl
prefLabel
Fluoroquinolone and macrolide ...... multidrug-resistant isolates.
@ast
Fluoroquinolone and macrolide ...... multidrug-resistant isolates.
@en
Fluoroquinolone and macrolide ...... multidrug-resistant isolates.
@nl
P2093
P2860
P356
P1476
Fluoroquinolone and macrolide ...... multidrug-resistant isolates.
@en
P2093
Emilio Pérez-Trallero
José M Marimon
Julián Larruskain
Luis Iglesias
P2860
P304
P356
10.3201/EID0909.020810
P577
2003-09-01T00:00:00Z